BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 8569441)

  • 1. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
    Jung CW; Jacobs P
    Magn Reson Imaging; 1995; 13(5):661-74. PubMed ID: 8569441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
    Jung CW
    Magn Reson Imaging; 1995; 13(5):675-91. PubMed ID: 8569442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10.
    Raynal I; Prigent P; Peyramaure S; Najid A; Rebuzzi C; Corot C
    Invest Radiol; 2004 Jan; 39(1):56-63. PubMed ID: 14701989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal size and properties of superparamagnetic iron oxide (SPIO) particles.
    Sjögren CE; Johansson C; Naevestad A; Sontum PC; Briley-Saebø K; Fahlvik AK
    Magn Reson Imaging; 1997; 15(1):55-67. PubMed ID: 9084026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.
    Varallyay P; Nesbit G; Muldoon LL; Nixon RR; Delashaw J; Cohen JI; Petrillo A; Rink D; Neuwelt EA
    AJNR Am J Neuroradiol; 2002 Apr; 23(4):510-9. PubMed ID: 11950637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the magnetic properties of iron oxide nanoparticles used as contrast agent for MRI.
    Pouliquen D; Perroud H; Calza F; Jallet P; Le Jeune JJ
    Magn Reson Med; 1992 Mar; 24(1):75-84. PubMed ID: 1556931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of AMI-227 as an oral MR contrast agent.
    Rogers J; Lewis J; Josephson L
    Magn Reson Imaging; 1994; 12(4):631-9. PubMed ID: 8057768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation and characterization of superparamagnetic iron oxide nanoparticles].
    Liu ST; Yan Y; Chen ZL; Zhang YZ; Jin X
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):331-4. PubMed ID: 16546740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and quality test of superparamagnetic iron oxide labeled antisense oligodeoxynucleotide probe: a preliminary study.
    Wen M; Li B; Ouyang Y; Luo Y; Li S
    Ann Biomed Eng; 2009 Jun; 37(6):1240-50. PubMed ID: 19337837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transmission electron microscopy in the structural study of superparamagnetic contrast agents for MRI].
    Lucet I; Filmon R; Pouliquen D; Le Jeune JJ; Jallet P
    Bull Assoc Anat (Nancy); 1994 Mar; 78(240):57-9. PubMed ID: 7519906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.
    Islam T; Wolf G
    Cancer Biomark; 2009; 5(2):69-73. PubMed ID: 19414923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging.
    Mahmoudi M; Simchi A; Imani M; Milani AS; Stroeve P
    J Phys Chem B; 2008 Nov; 112(46):14470-81. PubMed ID: 18729404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of ultrasmall magnetite [correction of paramagnetic magnetite] particles as superparamagnetic contrast agents in MRI.
    Grimm J; Karger N; Lüsse S; Winoto-Morbach S; Krisch B; Müller-Hülsbeck S; Heller M
    Invest Radiol; 2000 Sep; 35(9):553-6. PubMed ID: 10982000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ synthesis and characterization of magnetic nanoparticles in shells of biodegradable polyelectrolyte microcapsules.
    Lyubutin IS; Starchikov SS; Bukreeva TV; Lysenko IA; Sulyanov SN; Korotkov NY; Rumyantseva SS; Marchenko IV; Funtov KO; Vasiliev AL
    Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():225-33. PubMed ID: 25491824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of iron oxides on proton relaxivity.
    Josephson L; Lewis J; Jacobs P; Hahn PF; Stark DD
    Magn Reson Imaging; 1988; 6(6):647-53. PubMed ID: 2850434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ analysis of a bimodal size distribution of superparamagnetic nanoparticles.
    Thünemann AF; Rolf S; Knappe P; Weidner S
    Anal Chem; 2009 Jan; 81(1):296-301. PubMed ID: 19117457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superparamagnetic iron oxide for liver imaging. Comparison among three different preparations.
    Bach-Gansmo T; Fahlvik AK; Ericsson A; Hemmingsson A
    Invest Radiol; 1994 Mar; 29(3):339-44. PubMed ID: 8175309
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.